99mTc‑FAPI‑46 Scintigraphy for Staging of Non–Small Cell Lung Carcinoma
We describe a 71‑year‑old man with squamous cell lung carcinoma who underwent metastasis work-up with CT scan and 99mTc‑MDP bone scintigraphy, which suggested limited extrathoracic skeletal involvement. Subsequent 99mTc‑FAPI‑46 scintigraphy revealed a substantially greater disease burden, identifying a more extensive nodal and skeletal metastases. These findings resulted in a decisive stage migration from an initially presumed oligometastatic to a clearly polymetastatic stage IV disease, with direct implications for therapeutic intent. This case underscores the potential clinical utility of 99mTc‑FAPI‑46 scan as a cost‑effective staging modality, particularly in settings where PET/CT is unavailable or financially prohibitive.
Authors
- Mohammad Moeini Nodeh (ORCID: https://orcid.org/0000-0002-3713-7671)
- Emran Askari (ORCID: https://orcid.org/0000-0002-2973-2251)
- Atena Aghaee (ORCID: https://orcid.org/0000-0002-1351-3142)
- Nasrin Raeisi (ORCID: https://orcid.org/0009-0005-2087-2169)
- Amin Saber Tanha (ORCID: https://orcid.org/0009-0008-0290-0412)
Institutions
- Mashhad University of Medical Sciences (IR)
Publication Details
- Journal
- Clinical Nuclear Medicine
- Published
- 2026-06-29
- DOI
- https://doi.org/10.1097/rlu.0000000000006539
- Primary Topic
- Peptidase Inhibition and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 0.00